Response Prediction in Oncology Clinical Trials
https://xtalks.com/webinars/response-prediction-in-oncology-clinical-trials
The live discussion “Response Prediction in Oncology Clinical Trials” has concluded. For those interested in learning about the latest technological innovations and advanced imaging techniques that can support the success of oncology clinical trials through quantitative insights, a recording of this event is available.
The webinar featured:
Professor Sotirios Bisdas, Lead Consultant at the Department of Neuroradiology at the National Hospital of Neurology and Neurosurgery in London, and Associate Professor of Neuroradiology at University College London, and Professor of Radiology at Eberhard Karls University Tübingen, Germany, Honorary Consultant Neuroradiologist at the Great Ormond Street Hospital for Children, and Neuro-oncology Imaging Research Lead.
Dr. Anitha Singareddy, a board-certified physician with over 13 years of experience in clinical research, the CRO industry, and medical imaging, with extensive experience in medical imaging in the solid tumor portfolio using RECIST 1.1, iRECIST, and other oncology review criteria.
Julia O’Lynn, who has extensive expertise in radiologic cross-sectional imaging and in-depth expertise in clinical trial design. She advises life science companies on how to use imaging-based markers to accelerate their drug development and ensure standardized imaging across multi-center trials.
To access a recording of this live discussion, please reach out to Image Analysis Group’s (IAG) imaging experts at imaging.experts@ia-grp.com.
IAG is a unique partner to life sciences companies, leading AI-powered drug development and precision medicine. IAG leverages expertise in medical imaging and the power of Dynamika™ – their proprietary cloud-based platform, to de-risk clinical development and deliver lifesaving therapies into the hands of patients much sooner.